The Case Western Reserve University Institutional Biosafety Committee meets once a month on the second Thursday of each month. The meeting location varies. Meetings are open to the public, please contact case-ibc@case.edu for more information. Attendance at meetings will result in your name being recorded in the meeting minutes, which will be made publicly available per NIH requirements.
All new research submissions and requests for continuing review are reviewed by the full committee. Amendments are required for key changes to research plans prior to initiation of changes and, depending on the nature of the change, may be reviewed by the full committee.
The deadline for submissions is four weeks prior to the meeting date. *An extra week is requested for review at the January meeting due to the holiday break.
| Deadline for Submissions | Meeting Date |
|---|---|
| August 11, 2025 | September 11, 2025 |
| September 9, 2025 | October 9, 2025 |
| October 13, 2025 | November 13, 2025 |
| November 11, 2025 | December 11, 2025 |
| December 8, 2025* | January 15, 2026 |
| January 12, 2026 | February 12, 2026 |
| February 12, 2026 | March 12, 2026 |
| March 9, 2026 | April 9, 2026 |
| April 14, 2026 | May 14, 2026 |
| May 11, 2026 | June 11, 2026 |
| June 9, 2026 | July 9, 2026 |
| July 13, 2026 | August 13, 2026 |
| August 10, 2026 | September 10, 2026 |
| September 8, 2026 | October 8, 2026 |
| October 12, 2026 | November 12, 2026 |
| November 10, 2026 | December 10, 2026 |
Meeting Minutes
In compliance with the NIH Office of Science Policy (OSP) and to promote maximal transparency under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the minutes from the CWRU IBC meetings are listed below.
2025
IBC meeting minutes will be redacted to protect private and/or proprietary information in accordance with Section IV-B-2-a-(6) of the NIH Guidelines.
External IBC administered by Sabai
Notices of Upcoming IBC Meetings for Human Gene Transfer Research will be posted here, when scheduled.
If a member of the general public wishes to attend, please contact the administrators of the Institutional Biosafety Committee at ibcteam@sabaiglobal.com or call Colleen Karlo (Regulatory Contact for the IBC) at 216.368.0838 for information on attending the convened meeting.
In compliance with the NIH Office of Science Policy (OSP) and to promote maximal transparency under the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, the minutes from the IBC meetings administered by Sabai are listed below.
IBC meeting minutes will be redacted to protect private and/or proprietary information in accordance with Section IV-B-2-a-(6) of the NIH Guidelines.